Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Girindus America | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Girindus America

Dr. Edward Huber has been named director of Analytical Development and Quality Control, Girindus.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Edward Huber has been named director of Analytical Development and Quality Control, Girindus. Dr. Huber will provide managerial and technical leadership in the areas of analytical development and quality control. He has 30 years of pharmaceutical experience in the area of structural elucidation, separations sciences, and the development and validation of analytical methods for the characterization and control of APIs and finished dosage forms.

Dr. Huber has held positions of increasing responsibility in analytical chemistry at Marion Merrell Dow, Hoechst Marion Roussel, Aventis and Patheon. Most recently he was director of Analytical Development within Patheon’s Pharmaceutical Development Services group.

“We are very pleased to have Ed on the Girindus leadership team,” said Dr. Mark Laskovics, Girindus president and chief operating officer. “We welcome his extensive expertise in both the technical and managerial areas of QC / Analytics which will reinforce the high quality and technical standards Girindus has achieved to date.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics